Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Child Psychol Psychiatry ; 62(6): 701-703, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33368287

RESUMO

In this issue, Rodrigues et al. (2020) present a systematic review with meta-analyses that reports the efficacy of five treatments for children with attention-deficit hyperactivity disorder symptoms in the context of autism spectrum disorder - (a) methylphenidate; (b) atomoxetine; (c) guanfacine; (d) aripiprazole; and (e) risperidone. In this commentary, we highlight the contrast between the scarce evidence base of treatment for ADHD in the context of autism and other subpopulations, such as tic disorders and intellectual disability, and the extensive evidence base of treatment for ADHD in general. The commentary weighs about the conundrum clinicians face of whether to rely on the limited evidence base of treatment for ADHD in subpopulation, or to derive conclusions from the larger body of evidence of treatment for ADHD in general. The commentary also discusses potential avenues for future research to address this clinical problem.


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade , Transtorno do Espectro Autista , Metilfenidato , Cloridrato de Atomoxetina/farmacologia , Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Transtorno do Espectro Autista/tratamento farmacológico , Criança , Guanfacina/farmacologia , Humanos , Metilfenidato/farmacologia
2.
Brain Res ; 983(1-2): 237-41, 2003 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-12914987

RESUMO

We investigated the effects of epinephrine on the reversible nerve conduction block induced by high [K(+)](o) using electrophysiological extracellular recordings in the isolated rat sciatic nerve in vitro. Bath application of 400 micro M epinephrine (EN) or norepinephrine (NE) reduced the high-potassium-induced compound action potentials (CAPs) blockage in both sensory and motor fibers. The beta-adrenoreceptor agonist isoproterenol mimicked the EN effect while the alpha-adrenoreceptor agonists phenylephrine and guanfacine did not affect the CAPs reduction. Addition of EN to normal ACSF partially reversed the nerve conduction blockage induced by high frequency stimulation. These results suggest that EN and NE modulate the electrophysiological properties of both sensory and motor axons, and they improve the nerve conduction under high [K(+)](o) by modulating nerve excitability.


Assuntos
Agonistas Adrenérgicos/farmacologia , Epinefrina/farmacologia , Condução Nervosa/efeitos dos fármacos , Potássio/antagonistas & inibidores , Potássio/toxicidade , Nervo Isquiático/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Agonistas alfa-Adrenérgicos/farmacologia , Agonistas Adrenérgicos beta/farmacologia , Animais , Axônios/efeitos dos fármacos , Eletrofisiologia , Guanfacina/farmacologia , Isoproterenol/farmacologia , Masculino , Neurônios Motores/efeitos dos fármacos , Neurônios Aferentes/efeitos dos fármacos , Fenilefrina/farmacologia , Ratos , Ratos Sprague-Dawley , Nervo Isquiático/citologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA